Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.20
-1.50 (-1.86%)
Apr 20, 2026, 1:24 PM CST

Handa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,35813,53010,57625,89116,0748,451
Market Cap Growth
7.88%27.93%-59.15%61.07%90.20%199.72%
Enterprise Value
9,70210,9658,08523,74715,8698,249
Last Close Price
80.7086.0073.58179.00118.6165.86
PE Ratio
16.7118.0522.3735.62--
PS Ratio
7.727.8212.7323.4081.32289.08
PB Ratio
2.362.393.399.3922.2918.25
P/TBV Ratio
2.732.774.899.5223.4619.80
P/FCF Ratio
58.9259.6821.5938.79--
P/OCF Ratio
54.8355.5421.2538.74--
EV/Sales Ratio
5.616.349.7321.4780.28282.15
EV/EBITDA Ratio
8.839.9819.2034.00--
EV/EBIT Ratio
10.3811.7419.3434.25--
EV/FCF Ratio
42.8048.3616.5135.58--
Debt / Equity Ratio
0.010.010.010.010.040.03
Debt / EBITDA Ratio
0.040.040.090.02--
Debt / FCF Ratio
0.210.210.080.02--
Net Debt / Equity Ratio
-0.65-0.65-0.57-0.84-0.47-0.59
Net Debt / EBITDA Ratio
-3.33-3.33-4.25-3.304.141.11
Net Debt / FCF Ratio
-16.14-16.14-3.65-3.451.591.47
Asset Turnover
0.370.370.260.580.310.05
Quick Ratio
36.4536.458.4912.8911.6310.05
Current Ratio
36.6036.608.7212.9613.0710.57
Return on Equity (ROE)
17.08%17.08%16.10%41.81%-6.76%-49.43%
Return on Assets (ROA)
12.51%12.51%8.07%22.64%-8.54%-29.36%
Return on Invested Capital (ROIC)
38.08%44.90%46.33%151.89%-30.57%-118.36%
Return on Capital Employed (ROCE)
16.20%16.20%13.10%24.50%-11.80%-54.20%
Earnings Yield
5.61%5.54%4.47%2.81%-0.25%-2.93%
FCF Yield
1.70%1.68%4.63%2.58%-1.32%-2.19%
Dividend Yield
2.48%2.33%2.04%0.56%--
Payout Ratio
31.52%31.52%29.84%---
Buyback Yield / Dilution
-10.02%-10.02%-4.73%-7.29%-6.65%-1.87%
Total Shareholder Return
-7.54%-7.70%-2.69%-6.73%-6.65%-1.87%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.